| Year |
Citation |
Score |
| 2024 |
Mével M, Pichard V, Bouzelha M, Alvarez-Dorta D, Lalys PA, Provost N, Allais M, Mendes A, Landagaray E, Ducloyer JB, Toublanc E, Galy A, Brument N, Lefevre GM, Gouin SG, ... ... Moullier P, et al. Mannose-coupled AAV2: A second-generation AAV vector for increased retinal gene therapy efficiency. Molecular Therapy. Methods & Clinical Development. 32: 101187. PMID 38327809 DOI: 10.1016/j.omtm.2024.101187 |
0.341 |
|
| 2021 |
Gernoux G, Guilbaud M, Devaux M, Journou M, Pichard V, Jaulin N, Léger A, Le Duff J, Deschamps JY, Le Guiner C, Moullier P, Cherel Y, Adjali O. AAV8 locoregional delivery induces long-term expression of an immunogenic transgene in macaques despite persisting local inflammation. Molecular Therapy. Methods & Clinical Development. 20: 660-674. PMID 33718516 DOI: 10.1016/j.omtm.2021.02.003 |
0.349 |
|
| 2020 |
Bey K, Deniaud J, Dubreil L, Joussemet B, Cristini J, Ciron C, Hordeaux J, Le Boulc'h M, Marche K, Maquigneau M, Guilbaud M, Moreau R, Larcher T, Deschamps JY, Fusellier M, ... ... Moullier P, et al. Intra-CSF AAV9 and AAVrh10 Administration in Nonhuman Primates: Promising Routes and Vectors for Which Neurological Diseases? Molecular Therapy. Methods & Clinical Development. 17: 771-784. PMID 32355866 DOI: 10.1016/J.Omtm.2020.04.001 |
0.408 |
|
| 2020 |
Vandamme C, Xicluna R, Hesnard L, Devaux M, Jaulin N, Guilbaud M, Duff JL, Couzinié C, Moullier P, Saulquin X, Adjali O. Tetramer-Based Enrichment of Preexisting Anti-AAV8 CD8+ T Cells in Human Donors Allows the Detection of a TEMRA Subpopulation. Frontiers in Immunology. 10: 3110. PMID 32038634 DOI: 10.3389/Fimmu.2019.03110 |
0.313 |
|
| 2020 |
Bertin B, Veron P, Leborgne C, Deschamps JY, Moullec S, Fromes Y, Collaud F, Boutin S, Latournerie V, van Wittenberghe L, Delache B, Le Grand R, Dereuddre-Bosquet N, Benveniste O, Moullier P, et al. Capsid-specific removal of circulating antibodies to adeno-associated virus vectors. Scientific Reports. 10: 864. PMID 31965041 DOI: 10.1038/S41598-020-57893-Z |
0.331 |
|
| 2020 |
Mével M, Bouzelha M, Leray A, Pacouret S, Guilbaud M, Penaud-Budloo M, Alvarez-Dorta D, Dubreil L, Gouin SG, Combal JP, Hommel M, Gonzalez-Aseguinolaza G, Blouin V, Moullier P, Adjali O, et al. Chemical modification of the adeno-associated virus capsid to improve gene delivery Chemical Science. 11: 1122-1131. DOI: 10.1039/C9Sc04189C |
0.393 |
|
| 2019 |
Guilbaud M, Devaux M, Couzinié C, Duff JL, Toromanoff A, Vandamme C, Jaulin N, Gernoux G, Larcher T, Moullier P, Guiner CL, Adjali O. 5 years of successful inducible transgene expression following locoregional AAV delivery in nonhuman primates with no detectable immunity Human Gene Therapy. PMID 30808235 DOI: 10.1089/Hum.2018.234 |
0.436 |
|
| 2018 |
François A, Bouzelha M, Lecomte E, Broucque F, Penaud-Budloo M, Adjali O, Moullier P, Blouin V, Ayuso E. Accurate Titration of Infectious AAV Particles Requires Measurement of Biologically Active Vector Genomes and Suitable Controls. Molecular Therapy. Methods & Clinical Development. 10: 223-236. PMID 30112419 DOI: 10.1016/J.Omtm.2018.07.004 |
0.354 |
|
| 2018 |
Domenger C, Allais M, François V, Léger A, Lecomte E, Montus M, Servais L, Voit T, Moullier P, Audic Y, Le Guiner C. RNA-Seq Analysis of an Antisense Sequence Optimized for Exon Skipping in Duchenne Patients Reveals No Off-Target Effect. Molecular Therapy. Nucleic Acids. 10: 277-291. PMID 29499940 DOI: 10.1016/J.Omtn.2017.12.008 |
0.344 |
|
| 2017 |
Le Meur G, Lebranchu P, Billaud F, Adjali O, Schmitt S, Bézieau S, Péréon Y, Valabregue R, Ivan C, Darmon C, Moullier P, Rolling F, Weber M. Safety and Long-Term Efficacy of AAV4 Gene Therapy in Patients with RPE65 Leber Congenital Amaurosis. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 29033008 DOI: 10.1016/J.Ymthe.2017.09.014 |
0.36 |
|
| 2017 |
Le Guiner C, Servais L, Montus M, Larcher T, Fraysse B, Moullec S, Allais M, François V, Dutilleul M, Malerba A, Koo T, Thibaut JL, Matot B, Devaux M, Le Duff J, ... ... Moullier P, et al. Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy. Nature Communications. 8: 16105. PMID 28742067 DOI: 10.1038/Ncomms16105 |
0.468 |
|
| 2017 |
Penaud-Budloo M, Lecomte E, Guy-Duché A, Saleun S, Roulet A, Lopez-Roques C, Tournaire B, Cogné B, Léger A, Blouin V, Lindenbaum P, Moullier P, Ayuso E. Accurate Identification and Quantification of DNA Species by Next-Generation Sequencing in Adeno-Associated Viral Vectors Produced in Insect Cells Human Gene Therapy Methods. 28: 148-162. PMID 28463571 DOI: 10.1089/Hgtb.2016.185 |
0.341 |
|
| 2017 |
Pacouret S, Bouzelha M, Shelke R, Andres-Mateos E, Xiao R, Maurer A, Mevel M, Turunen H, Barungi T, Penaud-Budloo M, Broucque F, Blouin V, Moullier P, Ayuso E, Vandenberghe LH. AAV-ID: a Rapid and Robust Assay for Batch-to-Batch Consistency Evaluation of AAV Preparations. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28427840 DOI: 10.1016/J.Ymthe.2017.04.001 |
0.355 |
|
| 2016 |
Tshilenge KT, Ameline B, Weber M, Mendes-Madeira A, Nedellec S, Biget M, Provost N, Libeau L, Blouin V, Deschamps JY, Le Meur G, Colle MA, Moullier P, Pichard V, Rolling F. Vitrectomy prior to intravitreal injection of AAV2/2 vector promotes efficient transduction of retinal ganglion cells in dogs and non-human primates. Human Gene Therapy Methods. PMID 27229628 DOI: 10.1089/Hgtb.2016.034 |
0.387 |
|
| 2016 |
D'Costa S, Blouin V, Broucque F, Penaud-Budloo M, François A, Perez IC, Le Bec C, Moullier P, Snyder RO, Ayuso E. Practical utilization of recombinant AAV vector reference standards: focus on vector genomes titration by free ITR qPCR. Molecular Therapy. Methods & Clinical Development. 5: 16019. PMID 27069952 DOI: 10.1038/Mtm.2016.19 |
0.384 |
|
| 2016 |
Pichard V, Provost N, Mendes-Madeira A, Libeau L, Hulin P, Tshilenge KT, Biget M, Ameline B, Deschamps JY, Weber M, Le Meur G, Colle MA, Moullier P, Rolling F. AAV-mediated Gene Therapy Halts Retinal Degeneration in PDE6β-deficient Dogs. Molecular Therapy : the Journal of the American Society of Gene Therapy. 24: 867-76. PMID 26857842 DOI: 10.1038/Mt.2016.37 |
0.401 |
|
| 2016 |
Neuberger EW, Perez I, Le Guiner C, Moser D, Ehlert T, Allais M, Moullier P, Simon P, Snyder RO. Establishment of two quantitative nested qPCR assays targeting the human EPO transgene. Gene Therapy. 23: 330-9. PMID 26752352 DOI: 10.1038/Gt.2016.2 |
0.361 |
|
| 2016 |
Vandamme C, Devaux M, Jaulin N, Guilbaud M, Duff JL, Hesnard L, Djamai H, Bonneville M, Moullier P, Saulquin X, Adjali O. 697. Phenotypic and Functional Characterisation of Human Anti-AAV CD8+ T Cells Using MHC Class I Tetramer-Associated Magnetic Enrichment Molecular Therapy. 24. DOI: 10.1016/S1525-0016(16)33505-5 |
0.333 |
|
| 2016 |
Guiner CL, Servais L, Montus M, Larcher T, Fraysse B, Moullec S, Koo T, Malerba A, Bec CL, Hebben M, Masurier C, Mingozzi F, Adjali O, Carlier P, Hogrel J, ... ... Moullier P, et al. 503. Adeno-Associated Virus Vector (AAV) Microdystrophin Gene Therapy Prolongs Survival and Restores Muscle Function in the Canine Model of Duchenne Muscular Dystrophy (DMD) Molecular Therapy. 24. DOI: 10.1016/S1525-0016(16)33312-3 |
0.464 |
|
| 2016 |
Dupont J, Tournaire B, Durand R, Marolleau B, Bertil E, Georger C, Lecomte E, Cogné B, Gjata B, vanWittenberghe L, Vignaud A, Snyder RO, Moullier P, Léger A. 390. Impact of a Treatment with Antioxidant on Gene Transfer Efficiency After Recombinant Adeno-Associated Vector Injection in a Mouse Model of Duchenne Muscular Dystrophy Molecular Therapy. 24. DOI: 10.1016/S1525-0016(16)33199-9 |
0.46 |
|
| 2016 |
Pacouret S, Mevel M, Bouzelha M, Maurer A, Shelke R, Xiao R, Penaud-Budloo M, Turunen H, Broucque F, Blouin V, Moullier P, Ayuso E, Vandenberghe LH. 34. Development and Validation of Identity and Homogeneity Assays for AAV Preparations Molecular Therapy. 24: S15. DOI: 10.1016/S1525-0016(16)32843-X |
0.374 |
|
| 2015 |
Lecomte E, Tournaire B, Cogné B, Dupont JB, Lindenbaum P, Martin-Fontaine M, Broucque F, Robin C, Hebben M, Merten OW, Blouin V, François A, Redon R, Moullier P, Léger A. Advanced Characterization of DNA Molecules in rAAV Vector Preparations by Single-stranded Virus Next-generation Sequencing. Molecular Therapy. Nucleic Acids. 4: e260. PMID 26506038 DOI: 10.1038/Mtna.2015.32 |
0.364 |
|
| 2015 |
Guan X, Wang Z, Czerniecki S, Mack D, François V, Blouin V, Moullier P, Childers M. Use of adeno-associated virus to enrich cardiomyocytes derived from human stem cells. Human Gene Therapy. Clinical Development. PMID 26177370 DOI: 10.1089/Hum.2015.052 |
0.351 |
|
| 2015 |
Dupont JB, Tournaire B, Georger C, Marolleau B, Jeanson-Leh L, Ledevin M, Lindenbaum P, Lecomte E, Cogné B, Dubreil L, Larcher T, Gjata B, Van Wittenberghe L, Le Guiner C, Penaud-Budloo M, ... ... Moullier P, et al. Short-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxidative damage to transgene mRNA. Molecular Therapy. Methods & Clinical Development. 2: 15010. PMID 26029721 DOI: 10.1038/Mtm.2015.10 |
0.368 |
|
| 2015 |
Zerah M, Piguet F, Colle MA, Raoul S, Deschamps JY, Deniaud J, Gautier B, Toulgoat F, Bieche I, Laurendeau I, Sondhi D, Souweidane MM, Cartier-Lacave N, Moullier P, Crystal RG, et al. Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates. Human Gene Therapy. Clinical Development. 26: 113-24. PMID 25758611 DOI: 10.1089/Humc.2014.139 |
0.425 |
|
| 2015 |
Hordeaux J, Dubreil L, Deniaud J, Iacobelli F, Moreau S, Ledevin M, Le Guiner C, Blouin V, Le Duff J, Mendes-Madeira A, Rolling F, Cherel Y, Moullier P, Colle MA. Efficient central nervous system AAVrh10-mediated intrathecal gene transfer in adult and neonate rats. Gene Therapy. 22: 316-24. PMID 25588740 DOI: 10.1038/Gt.2014.121 |
0.315 |
|
| 2015 |
Domenger C, Lardenois A, Allais M, François V, Montus M, Servais L, Voit T, Moullier P, Guiner CL. 143. Off-Target Analysis of a rAAV-U7snRNA Vector Used for the Treatment of Duchenne Patients By Exon Skipping Molecular Therapy. 23. DOI: 10.1016/S1525-0016(16)33748-0 |
0.409 |
|
| 2015 |
Guiner CL, Servais L, Montus M, Bodvael F, Gjata B, Hogrel JY, Carlier P, Moullec S, Masurier C, Adjali O, Mingozzi F, Koo T, Athanasopoulos T, Cherel Y, Mavilio F, ... ... Moullier P, et al. Adeno-associated virus vector (AAV) microdystrophin gene therapy prolongs survival and restores muscle function in the canine model of Duchenne muscular dystrophy (DMD) Neuromuscular Disorders. 25. DOI: 10.1016/J.Nmd.2015.06.458 |
0.415 |
|
| 2014 |
Moreau A, Vandamme C, Segovia M, Devaux M, Guilbaud M, Tilly G, Jaulin N, Le Duff J, Cherel Y, Deschamps JY, Anegon I, Moullier P, Cuturi MC, Adjali O. Generation and in vivo evaluation of IL10-treated dendritic cells in a nonhuman primate model of AAV-based gene transfer. Molecular Therapy. Methods & Clinical Development. 1: 14028. PMID 26015970 DOI: 10.1038/Mtm.2014.28 |
0.454 |
|
| 2014 |
Ayuso E, Blouin V, Lock M, McGorray S, Leon X, Alvira MR, Auricchio A, Bucher S, Chtarto A, Clark KR, Darmon C, Doria M, Fountain W, Gao G, Gao K, ... ... Moullier P, et al. Manufacturing and characterization of a recombinant adeno-associated virus type 8 reference standard material. Human Gene Therapy. 25: 977-87. PMID 25275822 DOI: 10.1089/Hum.2014.057 |
0.354 |
|
| 2014 |
Le Guiner C, Stieger K, Toromanoff A, Guilbaud M, Mendes-Madeira A, Devaux M, Guigand L, Cherel Y, Moullier P, Rolling F, Adjali O. Transgene regulation using the tetracycline-inducible TetR-KRAB system after AAV-mediated gene transfer in rodents and nonhuman primates. Plos One. 9: e102538. PMID 25248159 DOI: 10.1371/Journal.Pone.0102538 |
0.44 |
|
| 2014 |
Le Guiner C, Montus M, Servais L, Cherel Y, Francois V, Thibaud JL, Wary C, Matot B, Larcher T, Guigand L, Dutilleul M, Domenger C, Allais M, Beuvin M, Moraux A, ... ... Moullier P, et al. Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1923-35. PMID 25200009 DOI: 10.1038/Mt.2014.151 |
0.38 |
|
| 2014 |
Chuah MK, Petrus I, De Bleser P, Le Guiner C, Gernoux G, Adjali O, Nair N, Willems J, Evens H, Rincon MY, Matrai J, Di Matteo M, Samara-Kuko E, Yan B, Acosta-Sanchez A, ... ... Moullier P, et al. Liver-specific transcriptional modules identified by genome-wide in silico analysis enable efficient gene therapy in mice and non-human primates. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1605-13. PMID 24954473 DOI: 10.1038/Mt.2014.114 |
0.426 |
|
| 2014 |
Bucher T, Dubreil L, Colle MA, Maquigneau M, Deniaud J, Ledevin M, Moullier P, Joussemet B. Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats. Gene Therapy. 21: 522-8. PMID 24572783 DOI: 10.1038/Gt.2014.16 |
0.333 |
|
| 2014 |
Childers MK, Joubert R, Poulard K, Moal C, Grange RW, Doering JA, Lawlor MW, Rider BE, Jamet T, Danièle N, Martin S, Rivière C, Soker T, Hammer C, Van Wittenberghe L, ... ... Moullier P, et al. Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy. Science Translational Medicine. 6: 220ra10. PMID 24452262 DOI: 10.1126/Scitranslmed.3007523 |
0.462 |
|
| 2014 |
Lhériteau E, Petit L, Weber M, Le Meur G, Deschamps JY, Libeau L, Mendes-Madeira A, Guihal C, François A, Guyon R, Provost N, Lemoine F, Papal S, El-Amraoui A, Colle MA, ... Moullier P, et al. Successful gene therapy in the RPGRIP1-deficient dog: a large model of cone-rod dystrophy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 265-77. PMID 24091916 DOI: 10.1038/Mt.2013.232 |
0.383 |
|
| 2014 |
Denard J, Jenny C, Blouin V, Moullier P, Svinartchouk F. Different protein composition and functional properties of adeno-associated virus-6 vector manufactured from the culture medium and cell lysates Molecular Therapy - Methods and Clinical Development. 1. DOI: 10.1038/Mtm.2014.31 |
0.384 |
|
| 2014 |
Servais L, Guiner CL, Montus M, Cherel Y, Francois V, Thibaud JL, Wary C, Matot B, Larche T, Guigand L, Dutilleul M, Goubin H, Deschamps JY, Domenger C, Allais M, ... ... Moullier P, et al. G.P.92 Neuromuscular Disorders. 24: 822. DOI: 10.1016/J.Nmd.2014.06.106 |
0.384 |
|
| 2014 |
Mack DL, Goddard M, Snyder JM, Doering J, Lawlor MW, Moullier P, O’Callaghan M, Beggs AH, Mavilio F, Poulard K, Latournerie V, Buj-Bello A, Childers M. G.P.41 Neuromuscular Disorders. 24: 807. DOI: 10.1016/J.Nmd.2014.06.055 |
0.389 |
|
| 2013 |
Perez IC, Le Guiner C, Ni W, Lyles J, Moullier P, Snyder RO. PCR-based detection of gene transfer vectors: application to gene doping surveillance. Analytical and Bioanalytical Chemistry. 405: 9641-53. PMID 23912835 DOI: 10.1007/S00216-013-7264-8 |
0.377 |
|
| 2013 |
Bucher T, Colle MA, Wakeling E, Dubreil L, Fyfe J, Briot-Nivard D, Maquigneau M, Raoul S, Cherel Y, Astord S, Duque S, Marais T, Voit T, Moullier P, Barkats M, et al. scAAV9 intracisternal delivery results in efficient gene transfer to the central nervous system of a feline model of motor neuron disease. Human Gene Therapy. 24: 670-82. PMID 23799774 DOI: 10.1089/Hum.2012.218 |
0.325 |
|
| 2013 |
Guiner CL, Montus M, Servais L, Cherel Y, Hogrel JY, Carlier P, Masurier C, Adjali O, Mavilio F, Dickson G, Moullier P, Voit T. P.20.13 Gene therapy of Duchenne Muscular Dystrophy using rAAV vectors: Exon skipping and microdystrophin approaches in GRMD dogs Neuromuscular Disorders. 23: 842-843. DOI: 10.1016/J.Nmd.2013.06.703 |
0.439 |
|
| 2013 |
Cherel Y, Guiner CL, Guigand L, Dutilleul M, Larcher T, Goubin H, Fraysse B, Deschamps JY, Montus M, Servais L, Voit T, Moullier P. P.20.12 Gene therapy of Duchenne Muscular Dystrophy using rAAV vectors: Patterns of dystrophin expression and histological improvements Neuromuscular Disorders. 23: 842. DOI: 10.1016/J.Nmd.2013.06.702 |
0.398 |
|
| 2013 |
Childers M, Joubert R, Poulard K, Holder M, Grange R, Doering J, Lawlor M, Moal C, Jamet T, Danièle N, Martin C, Rivière C, Poppante K, Soker T, Hammer C, ... ... Moullier P, et al. P.4.3 Intravenous infusion of AAV8–MTM1 prolongs life and ameliorates severe muscle pathology in mouse and dog models of X-linked myotubular myopathy Neuromuscular Disorders. 23: 760. DOI: 10.1016/J.Nmd.2013.06.441 |
0.412 |
|
| 2013 |
Joubert R, Moal C, Vignaud A, Martin S, Richard I, Moullier P, Beggs AH, Childers MK, Mavilio F, Buj-Bello A. O.6 Restricting MTM1 transgene expression to skeletal muscle in AAV-mediated gene therapy for myotubular myopathy Neuromuscular Disorders. 23: 741. DOI: 10.1016/J.Nmd.2013.06.384 |
0.423 |
|
| 2012 |
Petit L, Lhériteau E, Weber M, Le Meur G, Deschamps JY, Provost N, Mendes-Madeira A, Libeau L, Guihal C, Colle MA, Moullier P, Rolling F. Restoration of vision in the pde6β-deficient dog, a large animal model of rod-cone dystrophy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 2019-30. PMID 22828504 DOI: 10.1038/Mt.2012.134 |
0.363 |
|
| 2012 |
Veron P, Leborgne C, Monteilhet V, Boutin S, Martin S, Moullier P, Masurier C. Humoral and cellular capsid-specific immune responses to adeno-associated virus type 1 in randomized healthy donors Journal of Immunology. 188: 6418-6424. PMID 22593612 DOI: 10.4049/Jimmunol.1200620 |
0.39 |
|
| 2012 |
Denard J, Beley C, Kotin R, Lai-Kuen R, Blot S, Leh H, Asokan A, Samulski RJ, Moullier P, Voit T, Garcia L, Svinartchouk F. Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6. Journal of Virology. 86: 6620-31. PMID 22496229 DOI: 10.1128/Jvi.00297-12 |
0.381 |
|
| 2012 |
Nowrouzi A, Penaud-Budloo M, Kaeppel C, Appelt U, Guiner CL, Moullier P, Kalle Cv, Snyder RO, Schmidt M. Integration Frequency and Intermolecular Recombination of rAAV Vectors in Non-human Primate Skeletal Muscle and Liver Molecular Therapy. 20: 1177-1186. PMID 22453768 DOI: 10.1038/Mt.2012.47 |
0.385 |
|
| 2012 |
Moullier P, Snyder RO. Recombinant adeno-associated viral vector reference standards Methods in Enzymology. 507: 297-311. PMID 22365780 DOI: 10.1016/B978-0-12-386509-0.00015-6 |
0.431 |
|
| 2012 |
Beggs A, Jamet T, Joubert R, Furth M, Holder M, Grange R, Lawlor M, Viola M, Poulard K, Masurier C, Martin S, Rivière C, Poppante K, Soker T, Hammer C, ... ... Moullier P, et al. T.O.4 Development of AAV-gene and protein-based therapies for X-linked myotubular myopathy Neuromuscular Disorders. 22: 907. DOI: 10.1016/J.Nmd.2012.06.341 |
0.4 |
|
| 2012 |
Thibaud JL, Wary C, Moullec S, Azzabou N, Guiner CL, Garcia L, Montus M, Cherel Y, Fromes Y, Servais L, Roques S, Moullier P, Voit T, Carlier PG. T.P.23 Quantitative evaluation of locoregional high venous pressure rAAV8-U7- ESE6-ESE8 exon-skipping therapy in the GRMD dog using NMR 1H imaging and 31P spectroscopy Neuromuscular Disorders. 22: 859. DOI: 10.1016/J.Nmd.2012.06.188 |
0.318 |
|
| 2012 |
Hordeaux J, Moreau S, Dubreil L, Deniaud J, Iacobelli F, Joussemet B, Guiner CL, Moullier P, Chérel Y, Colle M-. Efficient Central Nervous System Transduction by Intracisternal AAV10 Gene Transfer in Rats Journal of Comparative Pathology. 146: 52. DOI: 10.1016/J.Jcpa.2011.11.029 |
0.336 |
|
| 2011 |
Joussemet B, Belbellaa B, Mendes-Madeira A, Bucher T, Briot-Nivard D, Dubreil L, Colle MA, Cherel Y, Moullier P, Rolling F. Neonatal systemic delivery of scAAV9 in rodents and large animals results in gene transfer to RPE cells in the retina. Experimental Eye Research. 93: 491-502. PMID 21723863 DOI: 10.1016/J.Exer.2011.06.012 |
0.415 |
|
| 2011 |
Léger A, Le Guiner C, Nickerson ML, McGee Im K, Ferry N, Moullier P, Snyder RO, Penaud-Budloo M. Adeno-associated viral vector-mediated transgene expression is independent of DNA methylation in primate liver and skeletal muscle. Plos One. 6: e20881. PMID 21687632 DOI: 10.1371/Journal.Pone.0020881 |
0.399 |
|
| 2011 |
Monteilhet V, Saheb S, Boutin S, Leborgne C, Veron P, Montus MF, Moullier P, Benveniste O, Masurier C. A 10 patient case report on the impact of plasmapheresis upon neutralizing factors against adeno-associated virus (AAV) types 1, 2, 6, and 8 Molecular Therapy. 19: 2084-2091. PMID 21629225 DOI: 10.1038/Mt.2011.108 |
0.421 |
|
| 2011 |
Ni W, Guiner CL, Gernoux G, Penaud-Budloo M, Moullier P, Snyder RO. Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: implications for gene doping Gene Therapy. 18: 709-718. PMID 21390073 DOI: 10.1038/Gt.2011.19 |
0.404 |
|
| 2011 |
Ellinwood NM, Ausseil J, Desmaris N, Bigou S, Liu S, Jens JK, Snella EM, Mohammed EE, Thomson CB, Raoul S, Joussemet B, Roux F, Chérel Y, Lajat Y, Piraud M, ... ... Moullier P, et al. Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and Hurler syndromes. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 251-9. PMID 21139569 DOI: 10.1038/Mt.2010.265 |
0.753 |
|
| 2010 |
Lhériteau E, Libeau L, Mendes-Madeira A, Deschamps JY, Weber M, Le Meur G, Provost N, Guihal C, Moullier P, Rolling F. Regulation of retinal function but nonrescue of vision in RPE65-deficient dogs treated with doxycycline-regulatable AAV vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1085-93. PMID 20354505 DOI: 10.1038/Mt.2010.46 |
0.41 |
|
| 2010 |
Toromanoff A, Adjali O, Larcher T, Hill M, Guigand L, Chenuaud P, Deschamps JY, Gauthier O, Blancho G, Vanhove B, Rolling F, Chérel Y, Moullier P, Anegon I, Le Guiner C. Lack of immunotoxicity after regional intravenous (RI) delivery of rAAV to nonhuman primate skeletal muscle. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 151-60. PMID 19888197 DOI: 10.1038/Mt.2009.251 |
0.421 |
|
| 2010 |
Colle MA, Piguet F, Bertrand L, Raoul S, Bieche I, Dubreil L, Sloothaak D, Bouquet C, Moullier P, Aubourg P, Cherel Y, Cartier N, Sevin C. Efficient intracerebral delivery of AAV5 vector encoding human ARSA in non-human primate. Human Molecular Genetics. 19: 147-58. PMID 19837699 DOI: 10.1093/Hmg/Ddp475 |
0.433 |
|
| 2009 |
Van Vliet K, Mohiuddin Y, McClung S, Blouin V, Rolling F, Moullier P, Agbandje-McKenna M, Snyder RO. Adeno-associated virus capsid serotype identification: Analytical methods development and application. Journal of Virological Methods. 159: 167-77. PMID 19447508 DOI: 10.1016/J.Jviromet.2009.03.020 |
0.334 |
|
| 2009 |
Stieger K, Belbellaa B, Le Guiner C, Moullier P, Rolling F. In vivo gene regulation using tetracycline-regulatable systems. Advanced Drug Delivery Reviews. 61: 527-41. PMID 19394373 DOI: 10.1016/J.Addr.2008.12.016 |
0.43 |
|
| 2009 |
Duque S, Joussemet B, Riviere C, Marais T, Dubreil L, Douar AM, Fyfe J, Moullier P, Colle MA, Barkats M. Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1187-96. PMID 19367261 DOI: 10.1038/Mt.2009.71 |
0.362 |
|
| 2009 |
Stieger K, Lhériteau E, Lhéariteau E, Moullier P, Rolling F. AAV-mediated gene therapy for retinal disorders in large animal models. Ilar Journal. 50: 206-24. PMID 19293463 DOI: 10.1093/Ilar.50.2.206 |
0.411 |
|
| 2009 |
Ciron C, Cressant A, Roux F, Raoul S, Cherel Y, Hantraye P, Déglon N, Schwartz B, Barkats M, Heard JM, Tardieu M, Moullier P, Colle MA. Human alpha-iduronidase gene transfer mediated by adeno-associated virus types 1, 2, and 5 in the brain of nonhuman primates: vector diffusion and biodistribution. Human Gene Therapy. 20: 350-60. PMID 19272011 DOI: 10.1089/Hum.2008.155 |
0.614 |
|
| 2009 |
Lhériteau E, Libeau L, Stieger K, Deschamps JY, Mendes-Madeira A, Provost N, Lemoine F, Mellersh C, Ellinwood NM, Cherel Y, Moullier P, Rolling F. The RPGRIP1-deficient dog, a promising canine model for gene therapy. Molecular Vision. 15: 349-61. PMID 19223988 |
0.666 |
|
| 2009 |
Stieger K, Schroeder J, Provost N, Mendes-Madeira A, Belbellaa B, Le Meur G, Weber M, Deschamps JY, Lorenz B, Moullier P, Rolling F. Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 516-23. PMID 19107120 DOI: 10.1038/Mt.2008.283 |
0.425 |
|
| 2009 |
Moreau A, Vicente R, Dubreil L, Adjali O, Podevin G, Jacquet C, Deschamps JY, Klatzmann D, Cherel Y, Taylor N, Moullier P, Zimmermann VS. Efficient intrathymic gene transfer following in situ administration of a rAAV serotype 8 vector in mice and nonhuman primates. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 472-9. PMID 19088703 DOI: 10.1038/Mt.2008.272 |
0.455 |
|
| 2009 |
Ciron C, Cressant A, Roux F, Raoul S, Cherel Y, Hantraye P, Deglon N, Schwartz B, Barkats M, Heard JM, Tardieu M, Moullier P, Colle M. AAV1-, AAV2- and AAV5-Mediated human α-Iduronidase Gene Transfer In The Brain of Nonhuman Primate: Vector Diffusion and Bio Distribution Human Gene Therapy. 90106063907063. DOI: 10.1089/Hgt.2008.155 |
0.359 |
|
| 2008 |
Toromanoff A, Chérel Y, Guilbaud M, Penaud-Budloo M, Snyder RO, Haskins ME, Deschamps JY, Guigand L, Podevin G, Arruda VR, High KA, Stedman HH, Rolling F, Anegon I, Moullier P, et al. Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal Muscle. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1291-1299. PMID 28178483 DOI: 10.1038/Mt.2008.87 |
0.674 |
|
| 2008 |
Moullier P, Snyder RO. International efforts for recombinant adeno-associated viral vector reference standards. Molecular Therapy. 16: 1185-1188. PMID 18574495 DOI: 10.1038/Mt.2008.125 |
0.374 |
|
| 2008 |
Penaud-Budloo M, Le Guiner C, Nowrouzi A, Toromanoff A, Chérel Y, Chenuaud P, Schmidt M, von Kalle C, Rolling F, Moullier P, Snyder RO. Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle. Journal of Virology. 82: 7875-85. PMID 18524821 DOI: 10.1128/Jvi.00649-08 |
0.407 |
|
| 2008 |
Toromanoff A, Chérel Y, Guilbaud M, Penaud-Budloo M, Snyder RO, Haskins ME, Deschamps JY, Guigand L, Podevin G, Arruda VR, High KA, Stedman HH, Rolling F, Anegon I, Moullier P, et al. Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1291-9. PMID 18461055 DOI: 10.1038/mt.2008.87 |
0.629 |
|
| 2008 |
Stieger K, Colle MA, Dubreil L, Mendes-Madeira A, Weber M, Le Meur G, Deschamps JY, Provost N, Nivard D, Cherel Y, Moullier P, Rolling F. Subretinal delivery of recombinant AAV serotype 8 vector in dogs results in gene transfer to neurons in the brain. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 916-23. PMID 18388922 DOI: 10.1038/Mt.2008.41 |
0.435 |
|
| 2008 |
Guilbaud M, Chadeuf G, Avolio F, François A, Moullier P, Recchia A, Salvetti A. Relative Influence of the Adeno-Associated Virus (AAV) Type 2 p5 Element for Recombinant AAV Vector Site-Specific Integration Journal of Virology. 82: 2590-2593. PMID 18094174 DOI: 10.1128/Jvi.01956-07 |
0.376 |
|
| 2007 |
Le Guiner C, Stieger K, Snyder RO, Rolling F, Moullier P. Immune responses to gene product of inducible promoters. Current Gene Therapy. 7: 334-46. PMID 17979680 DOI: 10.2174/156652307782151461 |
0.365 |
|
| 2006 |
Le Meur G, Stieger K, Smith AJ, Weber M, Deschamps JY, Nivard D, Mendes-Madeira A, Provost N, Péréon Y, Cherel Y, Ali RR, Hamel C, Moullier P, Rolling F. Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium. Gene Therapy. 14: 292-303. PMID 17024105 DOI: 10.1038/Sj.Gt.3302861 |
0.415 |
|
| 2006 |
Ciron C, Desmaris N, Colle MA, Raoul S, Joussemet B, Vérot L, Ausseil J, Froissart R, Roux F, Chérel Y, Ferry N, Lajat Y, Schwartz B, Vanier MT, Maire I, ... ... Moullier P, et al. Gene therapy of the brain in the dog model of Hurler's syndrome. Annals of Neurology. 60: 204-13. PMID 16718701 DOI: 10.1002/Ana.20870 |
0.637 |
|
| 2006 |
Stieger K, Le Meur G, Lasne F, Weber M, Deschamps JY, Nivard D, Mendes-Madeira A, Provost N, Martin L, Moullier P, Rolling F. Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 967-75. PMID 16442848 DOI: 10.1016/J.Ymthe.2005.12.001 |
0.421 |
|
| 2006 |
Toromanoff A, Hill M, Cherel Y, Deschamps J, Gauthier O, Vanhove B, Rolling F, Moullier P, Anegon I, Guiner CL. 974. Constitutive Expression of a Mutated Form of CTLA4Ig after Gene Transfer Is Well Tolerated and Prevents Immune Responses Against an Immunogenic Transgene in Nonhuman Primates Molecular Therapy. 13. DOI: 10.1016/J.Ymthe.2006.08.1067 |
0.38 |
|
| 2006 |
Toromanoff A, Cherel Y, Deschamps J, Arruda VR, High KA, Stedman HH, Haskins ME, Rolling F, Anegon I, Moullier P, Le Guiner C. 39. Evaluation of rAAV-1 vs rAAV-8 Vectors and Their Mode of Delivery in Nonhuman Primate Skeletal Muscle Molecular Therapy. 13: S16-S17. DOI: 10.1016/J.Ymthe.2006.08.052 |
0.378 |
|
| 2005 |
François A, Guilbaud M, Awedikian R, Chadeuf G, Moullier P, Salvetti A. The Cellular TATA Binding Protein Is Required for Rep-Dependent Replication of a Minimal Adeno-Associated Virus Type 2 p5 Element Journal of Virology. 79: 11082-11094. PMID 16103159 DOI: 10.1128/Jvi.79.17.11082-11094.2005 |
0.329 |
|
| 2005 |
Chadeuf G, Ciron C, Moullier P, Salvetti A. Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery. Molecular Therapy. 12: 744-753. PMID 16023415 DOI: 10.1016/J.Ymthe.2005.06.003 |
0.433 |
|
| 2005 |
Fraefel C, Mendes-Madeira A, Mabon O, Lefebvre A, Meur GL, Ackermann M, Moullier P, Rolling F. In vivo gene transfer to the rat retina using herpes simplex virus type 1 (HSV-1)-based amplicon vectors. Gene Therapy. 12: 1283-1288. PMID 15889134 DOI: 10.1038/Sj.Gt.3302553 |
0.39 |
|
| 2005 |
Awedikian R, François A, Guilbaud M, Moullier P, Salvetti A. Intracellular route and biological activity of exogenously delivered Rep proteins from the adeno-associated virus type 2. Virology. 335: 252-263. PMID 15840524 DOI: 10.1016/J.Virol.2005.02.024 |
0.354 |
|
| 2005 |
Le Meur G, Weber M, Péréon Y, Mendes-Madeira A, Nivard D, Deschamps JY, Moullier P, Rolling F. Postsurgical assessment and long-term safety of recombinant adeno-associated virus-mediated gene transfer into the retinas of dogs and primates. Archives of Ophthalmology (Chicago, Ill. : 1960). 123: 500-6. PMID 15824224 DOI: 10.1001/Archopht.123.4.500 |
0.384 |
|
| 2005 |
Grez M, Galun E, Moullier P. The twelfth annual meeting of the European Society of Gene Therapy. Molecular Therapy. 11: 178-179. PMID 15717416 DOI: 10.1016/J.Ymthe.2004.12.013 |
0.349 |
|
| 2005 |
Provost N, Le Meur G, Weber M, Mendes-Madeira A, Podevin G, Cherel Y, Colle MA, Deschamps JY, Moullier P, Rolling F. Biodistribution of rAAV vectors following intraocular administration: evidence for the presence and persistence of vector DNA in the optic nerve and in the brain. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 275-83. PMID 15668139 DOI: 10.1016/J.Ymthe.2004.09.022 |
0.385 |
|
| 2005 |
Moullier P. Editorial [Hot Topic: Recombinant Adeno-Associated Virus: Current Achievements and Limitations (Guest Editor: Philippe Moullier)] Current Gene Therapy. 5: 263-263. DOI: 10.2174/1566523054065002 |
0.311 |
|
| 2004 |
Geoffroy M, Epstein AL, Toublanc E, Moullier P, Salvetti A. Herpes Simplex Virus Type 1 ICP0 Protein Mediates Activation of Adeno-Associated Virus Type 2 rep Gene Expression from a Latent Integrated Form Journal of Virology. 78: 10977-10986. PMID 15452218 DOI: 10.1128/Jvi.78.20.10977-10986.2004 |
0.386 |
|
| 2004 |
Serhan F, Penaud M, Petit C, Leste-Lasserre T, Trajcevski S, Klatzmann D, Duisit G, Sonigo P, Moullier P. Early Detection of a Two-Long-Terminal-Repeat Junction Molecule in the Cytoplasm of Recombinant Murine Leukemia Virus-Infected Cells Journal of Virology. 78: 6190-6199. PMID 15163712 DOI: 10.1128/Jvi.78.12.6190-6199.2004 |
0.324 |
|
| 2004 |
Toublanc E, Benraiss A, Bonnin D, Blouin V, Brument N, Cartier N, Epstein AL, Moullier P, Salvetti A. Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines Journal of Gene Medicine. 6: 555-564. PMID 15133766 DOI: 10.1002/Jgm.542 |
0.373 |
|
| 2004 |
Chenuaud P, Larcher T, Rabinowitz JE, Provost N, Joussemet B, Bujard H, Samulski RJ, Favre D, Moullier P. Optimal design of a single recombinant adeno-associated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 410-8. PMID 15006608 DOI: 10.1016/J.Ymthe.2003.12.015 |
0.432 |
|
| 2004 |
Blouin V, Brument N, Toublanc E, Raimbaud I, Moullier P, Salvetti A. Improving rAAV production and purification: Towards the definition of a scaleable process Journal of Gene Medicine. 6. PMID 14978765 DOI: 10.1002/Jgm.505 |
0.361 |
|
| 2004 |
Chenuaud P, Larcher T, Rabinowitz JE, Provost N, Cherel Y, Casadevall N, Samulski RJ, Moullier P. Autoimmune anemia in macaques following erythropoietin gene therapy. Blood. 103: 3303-4. PMID 14739218 DOI: 10.1182/Blood-2003-11-3845 |
0.445 |
|
| 2004 |
Podevin G, Otta E, Nguyen JM, Pichard V, Aubert D, Moullier P, Ferry N. Factors influencing immune response after in vivo retrovirus-mediated gene transfer to the liver. The Journal of Gene Medicine. 6: 16-21. PMID 14716673 DOI: 10.1002/Jgm.469 |
0.37 |
|
| 2004 |
Chenuaud P, Larcher T, Rabinowitz J, Provost N, Cherel Y, Casadevall N, Samulski J, Moullier P. 1050. Autoimmune Anemia in Macaques Following Erythropoietin Gene Therapy Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.995 |
0.444 |
|
| 2003 |
Folliot S, Briot D, Conrath H, Provost N, Cherel Y, Moullier P, Rolling F. Sustained tetracycline-regulated transgene expression in vivo in rat retinal ganglion cells using a single type 2 adeno-associated viral vector. The Journal of Gene Medicine. 5: 493-501. PMID 12797114 DOI: 10.1002/Jgm.367 |
0.421 |
|
| 2003 |
Weber M, Rabinowitz J, Provost N, Conrath H, Folliot S, Briot D, Chérel Y, Chenuaud P, Samulski J, Moullier P, Rolling F. Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery. Molecular Therapy : the Journal of the American Society of Gene Therapy. 7: 774-81. PMID 12788651 DOI: 10.1016/S1525-0016(03)00098-4 |
0.441 |
|
| 2003 |
Aubert D, Pichard V, Durand S, Moullier P, Ferry N. Cytotoxic immune response after retroviral-mediated hepatic gene transfer in rat does not preclude expression from adeno-associated virus 1 transduced muscles. Human Gene Therapy. 14: 473-81. PMID 12691612 DOI: 10.1089/104303403321467234 |
0.391 |
|
| 2003 |
Nony P, Chadeuf G, Tessier J, Moullier P, Salvetti A. Evidence for Packaging of rep-cap Sequences into Adeno-Associated Virus (AAV) Type 2 Capsids in the Absence of Inverted Terminal Repeats: a Model for Generation of rep-Positive AAV Particles Journal of Virology. 77: 776-781. PMID 12477885 DOI: 10.1128/Jvi.77.1.776-781.2003 |
0.356 |
|
| 2002 |
Brument N, Morenweiser R, Blouin V, Toublanc E, Raimbaud I, Chérel Y, Folliot S, Gaden F, Boulanger P, Kroner-Lux G, Moullier P, Rolling F, Salvetti A. A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5. Molecular Therapy : the Journal of the American Society of Gene Therapy. 6: 678-86. PMID 12436964 DOI: 10.1006/Mthe.2002.0719 |
0.348 |
|
| 2002 |
Favre D, Blouin V, Provost N, Spisek R, Porrot F, Bohl D, Marmé F, Chérel Y, Salvetti A, Hurtrel B, Heard JM, Rivière Y, Moullier P. Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus. Journal of Virology. 76: 11605-11. PMID 12388721 DOI: 10.1128/Jvi.76.22.11605-11611.2002 |
0.62 |
|
| 2002 |
Duisit G, Conrath H, Saleun S, Folliot S, Provost N, Cosset FL, Sandrin V, Moullier P, Rolling F. Five recombinant simian immunodeficiency virus pseudotypes lead to exclusive transduction of retinal pigmented epithelium in rat. Molecular Therapy : the Journal of the American Society of Gene Therapy. 6: 446-54. PMID 12377185 DOI: 10.1006/Mthe.2002.0690 |
0.351 |
|
| 2002 |
Serhan F, Jourdan N, Saleun S, Moullier P, Duisit G. Characterization of Producer Cell-Dependent Restriction of Murine Leukemia Virus Replication Journal of Virology. 76: 6609-6617. PMID 12050374 DOI: 10.1128/Jvi.76.13.6609-6617.2002 |
0.324 |
|
| 2002 |
Aubert D, Ménoret S, Chiari E, Pichard V, Durand S, Tesson L, Moullier P, Anegon I, Ferry N. Cytotoxic immune response blunts long-term transgene expression after efficient retroviral-mediated hepatic gene transfer in rat. Molecular Therapy : the Journal of the American Society of Gene Therapy. 5: 388-96. PMID 11945065 DOI: 10.1006/Mthe.2002.0561 |
0.38 |
|
| 2002 |
Nègre D, Duisit G, Mangeot P-, Moullier P, Darlix J-, Cosset F-. Lentiviral Vectors Derived from Simian Immunodeficiency Virus Current Topics in Microbiology and Immunology. 261: 53-74. PMID 11892253 DOI: 10.1007/978-3-642-56114-6_3 |
0.367 |
|
| 2001 |
Verdugo ME, Scarpino V, Moullier P, Haskins ME, Aguirre GD, Ray J. Adenoviral vector-mediated beta-glucuronidase cDNA transfer to treat MPS VII RPE in vitro. Current Eye Research. 23: 357-67. PMID 11910525 DOI: 10.1076/Ceyr.23.5.357.5444 |
0.357 |
|
| 2001 |
Favre D, Provost N, Blouin V, Blancho G, Chérel Y, Salvetti A, Moullier P. Immediate and long-term safety on recombinant adeno-associated virus injection into the nonhuman primate muscle Molecular Therapy. 4: 559-566. PMID 11735340 DOI: 10.1006/Mthe.2001.0494 |
0.406 |
|
| 2001 |
Nony P, Tessier J, Chadeuf G, Ward P, Giraud A, Dugast M, Linden RM, Moullier P, Salvetti A. Novel cis-acting replication element in the adeno-associated virus type 2 genome is involved in amplification of integrated rep-cap sequences. Journal of Virology. 75: 9991-4. PMID 11559833 DOI: 10.1128/Jvi.75.20.9991-9994.2001 |
0.337 |
|
| 2001 |
Serguera C, Sarkis C, Ridet J, Colin P, Moullier P, Mallet J. Primary Adult Human Astrocytes as an ex Vivo Vehicle for β-Glucuronidase Delivery in the Brain Molecular Therapy. 3: 875-881. PMID 11407901 DOI: 10.1006/Mthe.2001.0319 |
0.31 |
|
| 2001 |
Agard C, Ligeza C, Dupas B, Izembart A, Kouri CE, Moullier P, Ferry N. Immune-dependent distant bystander effect after adenovirus-mediated suicide gene transfer in a rat model of liver colorectal metastasis. Cancer Gene Therapy. 8: 128-136. PMID 11263528 DOI: 10.1038/Sj.Cgt.7700281 |
0.365 |
|
| 2001 |
Tessier J, Chadeuf G, Nony P, Avet-Loiseau H, Moullier P, Salvetti A. Characterization of Adenovirus-Induced Inverted Terminal Repeat-Independent Amplification of Integrated Adeno-Associated Virus rep-cap Sequences Journal of Virology. 75: 375-383. PMID 11119606 DOI: 10.1128/Jvi.75.1.375-383.2001 |
0.391 |
|
| 2000 |
Nègre D, Mangeot PE, Duisit G, Blanchard S, Vidalain PO, Leissner P, Winter AJ, Rabourdin-Combe C, Mehtali M, Moullier P, Darlix JL, Cosset FL. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells Gene Therapy. 7: 1613-1623. PMID 11083469 DOI: 10.1038/Sj.Gt.3301292 |
0.449 |
|
| 2000 |
Favre D, Cherel Y, Provost N, Blouin V, Ferry N, Moullier P, Salvetti A. Hyaluronidase enhances recombinant adeno-associated virus (rAAV)-mediated gene transfer in the rat skeletal muscle Gene Therapy. 7: 1417-1420. PMID 10981669 DOI: 10.1038/Sj.Gt.3301256 |
0.406 |
|
| 2000 |
Chadeuf G, Favre D, Tessier J, Provost N, Nony P, Kleinschmidt J, Moullier P, Salvetti A. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome. The Journal of Gene Medicine. 2: 260-8. PMID 10953917 DOI: 10.1002/1521-2254(200007/08)2:4<260::Aid-Jgm111>3.0.Co;2-8 |
0.402 |
|
| 1999 |
Duisit G, Saleun S, Douthe S, Barsoum J, Chadeuf G, Moullier P. Baculovirus vector requires electrostatic interactions including heparan sulfate for efficient gene transfer in mammalian cells. Journal of Gene Medicine. 1: 93-102. PMID 10738573 DOI: 10.1002/(Sici)1521-2254(199903/04)1:2<93::Aid-Jgm19>3.0.Co;2-1 |
0.36 |
|
| 1999 |
Izembart A, Aguado E, Gauthier O, Aubert D, Moullier P, Ferry N. In vivo retrovirus-mediated gene transfer to the liver of dogs results in transient expression and induction of a cytotoxic immune response. Human Gene Therapy. 10: 2917-2925. PMID 10609653 DOI: 10.1089/10430349950016339 |
0.387 |
|
| 1999 |
Duisit G, Salvetti A, Moullier P, Cosset F. Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines. Human Gene Therapy. 10: 189-200. PMID 10022544 DOI: 10.1089/10430349950018986 |
0.361 |
|
| 1999 |
Mauff BL, Boeffard F, Tesson L, Chadeuf G, Douthe S, Salvetti A, Moullier P, Soulillou JP, Anegon I. Analysis Of Gene Transfer Efficacy In Rat Islets With Adeno Virus, Adeno-Associated Virus And Baculovirus. Transplantation. 67. DOI: 10.1097/00007890-199904150-00256 |
0.368 |
|
| 1998 |
Salvetti A, Orève S, Chadeuf G, Favre D, Cherel Y, Champion-Arnaud P, David-Ameline J, Moullier P. Factors Influencing Recombinant Adeno-Associated Virus Production Human Gene Therapy. 9: 695-706. PMID 9551617 DOI: 10.1089/Hum.1998.9.5-695 |
0.367 |
|
| 1998 |
Bohl D, Salvetti A, Moullier P, Heard JM. Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector Blood. 92: 1512-1517. DOI: 10.1182/Blood.V92.5.1512.417K43_1512_1517 |
0.468 |
|
| 1997 |
Moullier P, Salvetti A, Champion-Arnaud P, Ronco PM. Gene transfer into the kidney: current status and limitations. Nephron. 77: 139-151. PMID 9346379 DOI: 10.1159/000190265 |
0.395 |
|
| 1996 |
Moullier P, Salvetti A, Bohl D, Danos O, Heard JM. [Gene therapy of lysosomal diseases]. Archives De PéDiatrie : Organe Officiel De La SociéTe FrançAise De PéDiatrie. 3: 65s-68s. PMID 8795971 DOI: 10.1016/0929-693X(96)85996-3 |
0.679 |
|
| 1995 |
Naffakh N, Moullier P, Salvetti A, Bohl D, Danos O, Heard JM. Delivery of therapeutic proteins from genetically-modified cells. Restorative Neurology and Neuroscience. 8: 67-9. PMID 21551810 DOI: 10.3233/Rnn-1995-81216 |
0.658 |
|
| 1995 |
Salvetti A, Moullier P, Cornet V, Brooks D, Hopwood JJ, Danos O, Heard JM. In vivo delivery of human alpha-L-iduronidase in mice implanted with neo-organs. Human Gene Therapy. 6: 1153-9. PMID 8527473 DOI: 10.1089/Hum.1995.6.9-1153 |
0.691 |
|
| 1995 |
Cartier N, Lopez J, Moullier P, Rocchiccioli F, Rolland MO, Jorge P, Mosser J, Mandel JL, Bougnères PF, Danos O, Aubourg P. Retroviral-mediated gene transfer corrects very-long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts Proceedings of the National Academy of Sciences of the United States of America. 92: 1674-1678. PMID 7878038 DOI: 10.1073/Pnas.92.5.1674 |
0.573 |
|
| 1995 |
Moullier P, Bohl D, Cardoso J, Heard JM, Danos O. Long-term delivery of a lysosomal enzyme by genetically modified fibroblasts in dogs. Nature Medicine. 1: 353-7. PMID 7585066 DOI: 10.1038/Nm0495-353 |
0.684 |
|
| 1994 |
Moullier P, Friedlander G, Calise D, Ronco P, Perricaudet M, Ferry N. Adenoviral-mediated gene transfer to renal tubular cells in vivo. Kidney International. 45: 1220-1225. PMID 8007594 DOI: 10.1038/Ki.1994.162 |
0.362 |
|
| 1993 |
Moullier P, Maréchal V, Danos O, Heard JM. Continuous systemic secretion of a lysosomal enzyme by genetically modified mouse skin fibroblasts. Transplantation. 56: 427-32. PMID 8356601 DOI: 10.1097/00007890-199308000-00034 |
0.683 |
|
| 1993 |
Moullier P, Bohl D, Heard JM, Danos O. Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts. Nature Genetics. 4: 154-9. PMID 8348154 DOI: 10.1038/Ng0693-154 |
0.67 |
|
| Show low-probability matches. |